Intraocular neutralizing antibodies against aflibercept in patients with age related macular degeneration
Abstract Purpose To detect immunoglobulins in aqueous humour of AMD patients after repeated administration of intravitreal aflibercept. Patients and methods Twenty-one patients (age: 77.85 ± 9.21 years) previously treated with intravitreal aflibercept due to wet type age-related macular degeneration...
Main Authors: | Andrea Gyenes, Lilla István, Fruzsina Benyó, András Papp, Miklós Resch, Noémi Sándor, Mihály Józsi, Zoltán Z. Nagy, Illés Kovács, Szilárd Kiss |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-01-01
|
Series: | BMC Ophthalmology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12886-022-02761-9 |
Similar Items
-
Effect of intravitreal aflibercept on recalcitrant diabetic macular edema
by: Kendra A. Klein, et al.
Published: (2017-04-01) -
Intravitreal aflibercept injection in Indian eyes with retinopathy of prematurity
by: Vasumathy Vedantham
Published: (2019-01-01) -
The effect of ranibizumab and aflibercept treatment on the prevalence of outer retinal tubulation and its influence on retreatment in neovascular age-related macular degeneration
by: Attila Kovacs, et al.
Published: (2018-11-01) -
Assessment of Visual Quality Improvement as a Result of Spectacle Personalization
by: Fruzsina Benyó, et al.
Published: (2023-08-01) -
Atrophy of retinal vessels in neovascular age-related macular degeneration following long-term treatment with 20 intravitreal anti-VEGF injections
by: Miklós D. Resch, et al.
Published: (2022-12-01)